两种估计多发性硬化相关死亡率方法的比较
研究基于OFSEP队列(n=37,524)及一个有死亡原因的比较子集(4,004例复发型多发性硬化女性),对比病因特异性框架(CSF)与超额死亡框架(EMF)估计多发性硬化归因死亡概率(PMS)。在比较子集中,EMF估计的30年PMS高于CSF,但两框架估计的存活概率接近;EMF无需死亡证明,概念上更合理。
要点
- 在比较子集中,EMF估计的30年PMS高于CSF,但两框架估计的存活概率接近。
- EMF无需死亡证明,概念上更合理,避免了判断死亡是否由多发性硬化直接或间接导致。
- 在OFSEP人群中,EMF估计的30年PMS因初始表型、性别和发病年龄而异。
核心结论
- EMF无需死亡证明,概念上更合理,因其避免了对每个个体判断死亡是否由多发性硬化直接或间接导致或是否本会发生,这在慢性病中尤其困难。
研究设计与样本
- 使用法国多发性硬化观察站(OFSEP,n=37,524)的数据,以及一个有死亡原因的比较子集(4,004例复发型多发性硬化女性)。
- CSF使用Aalen-Johansen方法估计概率;EMF从超额死亡风险估计,即多发性硬化患者相对于匹配一般人群预期死亡率的额外死亡率。
- PMS值在随访30年时估计:在比较子集中用两种框架按发病年龄组估计;在OFSEP人群中仅用EMF按初始表型、性别和发病年龄估计。
主要发现
- 在比较子集中,EMF估计的30年PMS高于CSF:最年轻组为10.9%(95%CI 8.3-13.6)vs 8.7%(6.4-11.8),最年长组为20.4%(11.3-29.5)vs 16.2%(8.7-30.2)。
- 在CSF中,未知原因死亡概率范围为1.5%(0.7-3.0)至6.4%(2.5-16.4),即使重新分配后,CSF的PMS值仍低于EMF。
- 两框架估计的存活概率接近;EMF vs CSF估计的POther在最年轻组为2.6%(2.5-2.6)vs 2.1%(1.2-3.9),在最年长组为18.1%(16.9-19.3)vs 26.4%(16.5-42.2)。
- 在OFSEP人群中,EMF估计的30年PMS在复发型多发性硬化患者中范围为7.5%(6.4-8.7)至24.0%(19.1-28.9),在原发进展型患者中范围为25.4%(21.1-29.7)至36.8%(28.3-45.3),取决于性别和年龄。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Determining whether multiple sclerosis (MS) causes death is challenging. Our objective was to contrast 2 frameworks to estimate probabilities of death attributed to MS (PMS) and other causes (Pother): the cause-specific framework (CSF), which requires the causes of death, and the excess mortality framework (EMF), which does not. METHODS: We used data from the Observatoire Français de la Sclérose en Plaques (OFSEP, n = 37,524) and from a comparative subset where causes of death were available (4,004 women with relapsing-onset MS [R-MS]). In CSF, the probabilities were estimated using the Aalen-Johansen method. In EMF, they were estimated from the excess mortality hazard, which is the additional mortality among patients with MS as compared with the expected mortality in the matched general population. PMS values were estimated at 30 years of follow-up, (1) with both frameworks in the comparative subset, by age group at onset, and (2) with EMF only in the OFSEP population, by initial phenotype, sex, and age at onset. RESULTS: In the comparative subset, the estimated 30-year PMS values were greater using EMF than CSF: 10.9% (95% CI 8.3-13.6) vs 8.7% (6.4-11.8) among the youngest and 20.4% (11.3-29.5) vs 16.2% (8.7-30.2) for the oldest groups, respectively. In the CSF, probabilities of death from unknown causes ranged from 1.5% (0.7-3.0) to 6.4% (2.5-16.4), and even after their reallocation, PMS values remained lower with CSF than with EMF. The estimated probabilities of being alive were close using the 2 frameworks, and the estimated POther (EMF vs CSF) was 2.6% (2.5-2.6) vs 2.1% (1.2-3.9) and 18.1% (16.9-19.3) vs 26.4% (16.5-42.2), respectively, for the youngest and oldest groups. In the OFSEP population, the estimated 30-year PMS values ranged from 7.5% (6.4-8.7) to 24.0% (19.1-28.9) in patients with R-MS and from 25.4% (21.1-29.7) to 36.8% (28.3-45.3) in primary progressive patients, depending on sex and age. DISCUSSION: EMF has the great advantage of not requiring death certificates, their quality being less than optimal. Conceptually, it also seems more relevant because it avoids having to state, for each individual, whether death was directly or indirectly caused by MS or whether it would have occurred anyway, which is especially difficult in such chronic diseases.
引用
- Rollot F, Uhry Z, Dantony E, et al. Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality. Neurology. 2023. PMID: 37827849. doi:10.1212/WNL.0000000000207925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。